GP2 Values

Submit site search
  • GP2 Opportunities

    By GP2 | GP2 Values

    Development is an important component of our program; our focus is to provide training and other funding opportunities for the next generation of Parkinson’s disease researchers around the world. GP2 will offer these opportunities to the entire neurodegeneration community through the course of the program.

  • Open Science Opens Doors

    By Bradford Casey | GP2 Values

    In GP2, underlying data, analytical processes, and results will be made available to the research community as quickly as possible, with minimal barriers to access and use. The latest blog post by Bradford Casey highlights the value and importance of open science.

  • A letter to the patient community from Randy Schekman, ASAP Scientific Director

    By Randy Schekman and Benjamin Stecher | GP2 Values

    ASAP Scientific Director, Randy Schekman, expresses his personal and professional connection with Parkinson's disease in a letter to the patient community, shared by patient advocate Benjamin Stecher.

  • Introduction to GP2

    By Andrew Singleton | GP2 Values

    In the first GP2 blog post, Andrew Singleton, NIH Distinguished Investigator and GP2 Lead, introduces the program's aims, values and vision.

  • A Blueprint for Training and Development in GP2

    By Alastair Noyce, Sara Bandres-Ciga, and Emily Fisher | Complex disease genetics, GP2 Values

    Training is a crucial element of GP2. In this blog post, Alastair Noyce, Sara Bandres-Ciga and Emily Fisher outline the program's training and development goals.

  • Introducing the GP2 Learning Platform

    By GP2 | GP2 Values

    Training is central to the GP2 effort. Visit our learning platform for training on topics related to Parkinson’s disease genetics.

  • Why study disease in different populations?

    By Ignacio Fernandez Mata | Complex disease genetics, GP2 Values

    GP2 aims to revolutionize our understanding of the genetics of Parkinson's disease across populations. Ignacio 'Nacho' Mata explains the importance of involving populations currently underserved in disease research.

Load More